Find out all about your favorite commercial!

Advertisers

Advertisers of the Tepezza TV Spot, 'Jeanne: $0 Co-Pay Available'

Tepezza TV commercial - Jeanne: $0 Co-Pay Available
Tepezza

What is Tepezza?Tepezza is a prescription medicine used to treat Thyroid Eye Disease (TED). It is manufactured by Horizon Therapeutics.Horizon TherapeuticsHorizon Therapeutics is a biopharmaceutical c...

What the Tepezza TV commercial - Jeanne: $0 Co-Pay Available is about.

Tepezza TV commercial - Jeanne: $0 Co-Pay Available

Tepezza is a medication that's used in the treatment of thyroid eye disease, a rare autoimmune disorder characterized by inflammation and tissue damage of the eyes. Recently, the Tepezza TV spot titled "Jeanne: $0 Co-Pay Available" made waves in the healthcare industry.

The TV spot features Jeanne, a middle-aged woman who's living with thyroid eye disease. Jeanne shares her story of how the condition had affected her life, causing her eyes to bulge and causing severe discomfort and pain. She had tried various treatments over the years, but nothing seemed to work.

Jeanne then decided to start using Tepezza after consulting with her doctor. The medication worked wonders and helped to reduce the inflammation in her eyes, thereby minimizing the symptoms of the disease. Jeanne mentions that she didn't experience any side effects and that the results were noticeable within six months.

The most remarkable part of the Tepezza TV spot is that it highlights the availability of a $0 co-pay program for eligible patients. Jeanne talks about how she was able to get her medication without paying a penny, thanks to the co-pay program. The TV spot encourages patients with thyroid eye disease to speak to their doctors about Tepezza and to check whether they're eligible for the program.

Overall, the Tepezza TV spot is informative, engaging, and empathetic towards patients with thyroid eye disease. It's a step in the right direction towards increasing awareness about the ailment and providing affordable treatment options for those in need.

Tepezza TV commercial - Jeanne: $0 Co-Pay Available produced for Tepezza was first shown on television on February 20, 2022.

Frequently Asked Questions about tepezza tv spot, 'jeanne: $0 co-pay available'

Since Tepezza is a biologic drug, it can't have a generic version. This is because biologics are made from living cells and can't be replicated exactly. Instead, it's possible for biologic drugs to have biosimilar versions. Biosimilars are just as safe and effective as the original biologic but often cost less.

TEPEZZA reduces eye bulging and double vision. It also improves the signs and symptoms of Thyroid Eye Disease (TED), including eye pain, redness, and swelling. TEPEZZA is a prescription medicine used to treat TED. You should discuss the risks and benefits of using TEPEZZA with your doctor.

Each vial contains 500 milligrams (mg) of the active drug, teprotumumab. Your healthcare professional will use the powder in the vial to make a solution. Then, they'll give the Tepezza solution to you as an intravenous (IV) infusion. (With an IV infusion, the drug is given into your vein over a period of time.)

How many patients have been treated with TEPEZZA? Over 14,500 TED patients have been treated with TEPEZZA.

Intravenous Powder For Injection

QuantityPer unitPrice
1$16,301.09$16,301.09

The manufacturer has priced Tepezza at $14,900 to $16,301.09 per vial in the United States. Treatment requires up to eight infusions. Total Tepezza cost will depend on your treatment plan. Coverage for Tepezza varies depending on health insurance plans.

Intravenous Powder For Injection

QuantityPer unitPrice
1$16,301.09$16,301.09

An insulin-like growth factor-1 receptor inhibitor, Tepezza is claimed to be the first and only medicine to receive approval from the FDA to treat TED, a rare progressive, debilitating and potentially vision-threatening autoimmune disease. The FDA's approval was granted in January 2020.

New York: Luxturna, a medication against hereditary degeneration of the retina that can lead to total blindness, will be sold for $850,000 in the United States, making it one of the world's most expensive medical treatments.

A new gene therapy called Luxturna for blindness will cost $850,000, says Spark Therapeutics, the company that makes it. Patients will get help paying for it.

Patient's prescription cannot be paid in part or in full by any government-funded program including but not limited to: Medicare, Medicare Part D, Medicaid, Medigap, VA, CHAMPUS, Department of Defense (DOD), TRICARE, or any state, patient foundation, or other pharmaceutical program.

Clinical studies have shown that Tepezza (teprotumumab) works well to improve eye symptoms, such as eye bulging, double vision, and eye pain and redness.

Videos

Watch Tepezza TV Commercial, 'Jeanne: $0 Co-Pay Available'

Unfortunately we were unable to find any suitable videos in the public domain. Perhaps the video of this TV commercial has not been preserved. If you know the link to this commercial, you can send it to us using a special form.

Products

Products Advertised

Tepezza
TV commercials

Similar commercials

Readers.com TV Spot, 'Over 700 Styles'
Readers.com TV Spot, 'Always a Great Selection'
Readers.com TV Spot, 'Hundreds of Styles'
Readers.com TV Spot, 'Exclusive TV Offer'
DeVry University TV Commercial Featuring Steven Holocomb
Miller Lite TV Spot, 'See and Say'
1-800 Contacts Express Exam TV Spot, 'Cat Massage'
Readers.com TV Spot, 'You Need Readers.com'
1-800 Contacts TV Spot, 'Through Their Eyes: 30%: That Easy'
Visionworks TV Spot, 'More Than Seeing Great'
Readers.com TV Spot, 'Special Look & Style'
1-800 Contacts TV Spot, 'Through Their Eyes: Hold On'